Takeda Gets FDA Clearance for HyHub™ Devices
Takeda(TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HyHubTM and HyHubTM Duo, devices for patients 17 years of age and...
Category : Healthcare and Pharmaceutical
Logical Biological Launches Logical Antigen for IVD Market
Logical Biological, biospecimen and critical material experts, today announced the launch of a new sister company, Logical Antigen, focused on rapid and customised delivery of...
Humana Speeds Up Prior Authorization Removal for Faster Care
New effort will expedite approvals, promote access to care, reduce administrative burdens, and enhance the patient experience Humana Inc., a leading health and well-being company,...
Protalix BioTherapeutics Names Gilad Mamlok SVP & CFO
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein...
Compugen Doses First Patient in COM701 Global Ovarian Cancer Trial
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today announced that the first patient...
MVP Health & Renalytix Partner to Expand Kidney Disease Testing
New partnership expands access to prognostic testing for people with diabetic kidney disease, helping improve lives and reduce health disparities. Renalytix Plc, a precision medicine...
Avantor Announces Emmanuel Ligner as Next President and CEO
Seasoned Executive with Proven Track Record of Value Creation in Life Sciences Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to...
Revalesio Publishes Phase 2 RESCUE Trial Results on RNS60 for Stroke
Trial met primary endpoints of similar rates of serious adverse events (SAEs) and fewer deaths observed with RNS60 versus placebo Statistically significant reduction in infarct...
Bakar Labs Opens New R&D Space for Growing Biotech Startups
– “Graduation” space designed to help growing life science companies remain in the ecosystem and thrive Bakar Labs, the University of California, Berkeley’s flagship incubator for life science,...
J&J Seeks FDA Approval for Icotrokinra to Treat Plaque Psoriasis
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor Filing based on unprecedented data package that met all primary endpoints...
Digostics Launches University Trial for At-Home Type 1 Diabetes Test
Researchers at Yale School of Medicine, funded by Breakthrough T1D, are evaluating GTT@home, a new finger-prick, at-home glucose tolerance test, to monitor early-stage type 1...
PathoCare Accepts Tender Offer at $500M, Plans New Equity Round
PathoCare Holdings, Inc.—the parent company of medical diagnostics innovator PathoCare, LLC (a leader in the Lab-on-a-Chip non-invasive Point of Care diagnostics)—has developed a set of...
Claritev Joins athenahealth Marketplace to Boost Price Insights
Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for...
Biocytogen, BeOne Sign Antibody Licensing Deal for Drug R&D
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies,...
Kihealth Wins ADA Award for Diabetes Diagnostic Innovation
Kihealth, a leader in molecular diagnostics, today announced it has won the Innovation of the Year challenge at the American Diabetes Association’s 85th Scientific Session held in Chicago....